<p>Cosara Diagnostics Private Limited, an Ahmedabad-based molecular diagnostic company, on Wednesday said that it has received the test license from Central Drugs Standard Control Organisation (CDSCO), the regulatory body, to manufacture coronavirus (COVID-19) diagnostic test kits.</p>.<p>Cosara is a joint venture between a group company of Ambalal Sarabhai Enterprises Limited (ASE) and USA’s Co-Diagnostics Inc, that has a CDSCO approved molecular diagnostic manufacturing plant in Ranoli in Vadodara district. In a release, the firm said that it will soon initiate manufacturing these test kits.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-live-updates-two-more-test-positive-in-karnataka-indias-tally-stands-at-151-799686.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>“We are thankful to the CDSCO for issuing this test license which allows us to manufacture this COVID-19 proprietary test that has a very high specificity, a turnaround time of around 2 hours and affordable which allows us to respond efficiently to this pandemic,” says Mohal Sarabhai, CEO and Director of the firm. </p>.<p>The company said that this test is designed to use nasopharyngeal, oro-pharyngeal swab and serum samples to detect the coronavirus using a polymerase chain reaction (PCR) machine.</p>.<p>“With no known treatment or approved vaccine for the highly-infectious COVID-19, the need for accurate and rapid diagnoses has never been greater. Our cost-effective Covid-19 test has been designed to run on a variety of commercially available platforms. We are confident in our ability to meet the growing demand for this diagnostic,” Dwight Egan, CEO of Co-Diagnostics Inc, USA, has been quoted in the release as saying.</p>
<p>Cosara Diagnostics Private Limited, an Ahmedabad-based molecular diagnostic company, on Wednesday said that it has received the test license from Central Drugs Standard Control Organisation (CDSCO), the regulatory body, to manufacture coronavirus (COVID-19) diagnostic test kits.</p>.<p>Cosara is a joint venture between a group company of Ambalal Sarabhai Enterprises Limited (ASE) and USA’s Co-Diagnostics Inc, that has a CDSCO approved molecular diagnostic manufacturing plant in Ranoli in Vadodara district. In a release, the firm said that it will soon initiate manufacturing these test kits.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-live-updates-two-more-test-positive-in-karnataka-indias-tally-stands-at-151-799686.html"><strong>For latest updates on coronavirus outbreak, click here</strong></a></p>.<p>“We are thankful to the CDSCO for issuing this test license which allows us to manufacture this COVID-19 proprietary test that has a very high specificity, a turnaround time of around 2 hours and affordable which allows us to respond efficiently to this pandemic,” says Mohal Sarabhai, CEO and Director of the firm. </p>.<p>The company said that this test is designed to use nasopharyngeal, oro-pharyngeal swab and serum samples to detect the coronavirus using a polymerase chain reaction (PCR) machine.</p>.<p>“With no known treatment or approved vaccine for the highly-infectious COVID-19, the need for accurate and rapid diagnoses has never been greater. Our cost-effective Covid-19 test has been designed to run on a variety of commercially available platforms. We are confident in our ability to meet the growing demand for this diagnostic,” Dwight Egan, CEO of Co-Diagnostics Inc, USA, has been quoted in the release as saying.</p>
